ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,143Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 1107

$1.27M Total Retail Price of All Prescriptions

Rank: 49 out of 1107

795 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 795 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

37% of this provider’s 795 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 15,885 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 2,292 1,098 S3 1 1
OMEPRAZOLE 886 404 2 4
SIMVASTATIN 864 496 3 5
AMLODIPINE BESYLATE 785 573 4 6
LISINOPRIL 780 451 5 2
FUROSEMIDE 736 480 6 7
GABAPENTIN 619 231 7 9
LEVOTHYROXINE SODIUM 587 442 8 3
METOPROLOL TARTRATE 535 341 9 10
METFORMIN HCL 521 253 10 8
ATENOLOL 496 317 11 19
HYDROCHLOROTHIAZIDE 431 297 12 11
IBUPROFEN 367 127 13 63
NEXIUM 318 154 14 18
CITALOPRAM HBR 295 112 15 17
POTASSIUM CHLORIDE 275 195 16 14
PROMETHAZINE HCL 273 67 R 17 44
RANITIDINE HCL 266 169 18 21
ATORVASTATIN CALCIUM 264 194 19 13
ZOLPIDEM TARTRATE 256 146 20 22
PANTOPRAZOLE SODIUM 247 160 21 30
PREDNISONE 242 159 22 40
POLYETHYLENE GLYCOL 3350 240 172 23 46
CLONIDINE HCL 237 109 24 53
ENDOCET 235 105 S2 25 91
SERTRALINE HCL 222 117 26 20
METOPROLOL SUCCINATE 194 97 27 16
DICLOFENAC SODIUM 189 86 28 74
HYDROXYZINE HCL 186 79 R 29 162
GLIPIZIDE 185 126 30 64
ENALAPRIL MALEATE 183 106 31 98
LIDODERM 181 169 32 140
FLUOXETINE HCL 179 83 33 47
TIZANIDINE HCL 177 66 34 73
TAMSULOSIN HCL 176 117 35 30
QUETIAPINE FUMARATE 168 68 36 94
CARVEDILOL 166 135 37 27
TRAZODONE HCL 166 90 37 33
LOVASTATIN 165 101 39 55
TRAMADOL HCL 163 128 40 26
CLOPIDOGREL 159 120 41 28
WARFARIN SODIUM 156 114 42 15
DONEPEZIL HCL 152 128 43 32
ISOSORBIDE MONONITRATE ER 151 89 44 34
CEPHALEXIN 151 74 44 81
PROAIR HFA 147 56 46 37
AMITRIPTYLINE HCL 142 65 R 47 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 67 48 24
GLYBURIDE 139 98 R 48 68
PROPRANOLOL HCL 134 91 50 134
PREMARIN 134 47 R 50 149
ROPINIROLE HCL 132 103 52 69
AZITHROMYCIN 130 64 53 35
PLAVIX 129 94 54 39
VENTOLIN HFA 128 50 55 97
LANTUS 126 48 56 49
CYMBALTA 121 20 57 50
CYCLOBENZAPRINE HCL 120 40 R 58 56
SPIRIVA 115 57 59 57
BUSPIRONE HCL 114 37 60 107
ALPRAZOLAM 111 75 61 87
PRAVASTATIN SODIUM 106 75 62 12
ADVAIR DISKUS 106 35 62 54
METHOCARBAMOL 104 37 R 64 142
CIPROFLOXACIN HCL 104 64 64 59
MIRTAZAPINE 103 62 66 61
CRESTOR 102 61 67 23
SYNTHROID 101 88 68 70
NYSTATIN 100 86 69 110
LOSARTAN POTASSIUM 99 61 70 29
PAROXETINE HCL 99 36 70 45
OXYBUTYNIN CHLORIDE 99 60 70 171
TRIAMTERENE-HCTZ 98 82 73 62
SEROQUEL 97 49 74 182
GLIMEPIRIDE 94 39 75 43
ESCITALOPRAM OXALATE 94 49 75 82
ACETAMINOPHEN-CODEINE 93 66 S3 77 120
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 48 77 88
LIPITOR 88 60 79 109
HYDROXYZINE PAMOATE 84 0 R 80 152
HYDRALAZINE HCL 81 58 81 99
METFORMIN HCL ER 81 29 81 58
TRIAMCINOLONE ACETONIDE 81 60 81 137
THEOPHYLLINE ANHYDROUS 81 62 81 158
METHADONE HCL 79 0 S2 85 201
LYRICA 79 17 85 83
LOSARTAN-HYDROCHLOROTHIAZIDE 78 58 87 66
ALENDRONATE SODIUM 74 60 88 41
NAMENDA 73 60 89 42
JANUVIA 72 46 90 60
DILTIAZEM ER 72 55 90 139
OXYCODONE HCL-ACETAMINOPHEN 72 14 S2 90 93
ALLOPURINOL 72 33 90 36
INSULIN SYRINGE 70 33 94 78
LEVETIRACETAM 68 39 95 141
FLUTICASONE PROPIONATE 68 37 95 38
MEGESTROL ACETATE 67 43 R 97 178
BUPROPION HCL SR 66 35 98 190
FLUCONAZOLE 65 21 99 150
DIOVAN HCT 65 38 99 106
LANSOPRAZOLE 65 25 99 102
DIGOXIN 64 48 102 52
NAPROXEN 62 23 103 80
MELOXICAM 62 45 103 25
SINGULAIR 61 31 105 65
KLOR-CON M20 60 48 106 75
TRICOR 59 40 107 95
RESTASIS 59 59 107 338
BUMETANIDE 58 53 109 123
LEVOFLOXACIN 58 32 109 71
METHOTREXATE 56 33 111 287
DIOVAN 56 43 111 51
SPIRONOLACTONE 56 56 111 72
LORAZEPAM 56 26 111 155
AMOXICILLIN 55 38 115 90
RAMIPRIL 55 55 115 84
OXYCONTIN 55 26 S2 115 167
TOPIRAMATE 54 13 118 160
AMIODARONE HCL 54 35 118 199
TRIAMTERENE-HYDROCHLOROTHIAZID 53 34 120 185
ONDANSETRON HCL 53 20 120 211
FAMOTIDINE 53 45 120 111
CARBAMAZEPINE 52 24 123 215
NASONEX 51 0 124 206
CARBIDOPA-LEVODOPA 50 40 125 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.